Atlas Trials

Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC

Clinical trial NCT06013943 · UNKNOWN

Trial details

NCT number
NCT06013943
Sponsor
Eastern Hepatobiliary Surgery Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gallbladder Cancer
Start date
2023-03-17
Primary completion
2025-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.